Activated Charcoal and Poisoning: Is It Really Effective?

Area of Science:

• Medical Toxicology
• Emergency Medicine
• Clinical Pharmacology

Background:

• Activated charcoal is widely used as a universal antidote for poisoning.
• Its clinical effectiveness in oral drug poisoning remains debated.
• This study compares outcomes in patients who did and did not receive activated charcoal.

Purpose of the Study:

• To evaluate the effectiveness of activated charcoal in patients with oral drug poisoning.
• To compare clinical outcomes between patients administered activated charcoal and those who were not.

Main Methods:

• Retrospective cohort study with historical controls.
• Inclusion of adult patients admitted for oral drug poisoning.
• Comparison of clinical findings, antidote use, intubation rates, and hospitalization length.

Main Results:

• No significant difference in central nervous system, cardiovascular, intubation, or blood gas outcomes.
• Fewer hepatobiliary and electrolyte issues in the activated charcoal group.
• Increased tachycardia, coma, and respiratory acidosis in the activated charcoal group.
• Longer hospitalization for drug findings in the activated charcoal group, but no difference for antidote use.

Conclusions:

• Activated charcoal may not offer substantial clinical benefits in poisoned patients.
• Higher incidence of certain adverse effects observed with activated charcoal administration.
• Further robust clinical trials are necessary to definitively establish the efficacy of activated charcoal.